OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
14 hedge funds and large institutions have $2.16M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.36M | |
| 2 | +$50.1K | |
| 3 | +$48.7K | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$11.1K |
| 5 |
RA
Royce & Associates
New York
|
+$2.29K |
Top Sellers
| 1 | -$774K | |
| 2 | -$238K | |
| 3 | -$199K | |
| 4 |
Morgan Stanley
New York
|
-$61.8K |
| 5 |
TCM
Tradewinds Capital Management
Bellingham,
Washington
|
-$57K |